Determination of paroxetine in geriatric depression by high-performance liquid chromatography.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Pharmacological Research

• Publication date

  2003-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S1043-6618(03)00098-7PMID 12798675
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography.

  2002cited by this paper
• High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum.

  2001cited by this paper
• Simultaneous determination of human plasma levels of four selective serotonin reuptake inhibitors by high-performance liquid chromatography.

  2000cited by this paper
• Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and gas chromatography.

  2000cited by this paper
• Therapeutic drug monitoring of selective serotonin reuptake inhibitors influences clinical dosing strategies and reduces drug costs in depressed elderly patients

  2000cited by this paper
• Determination of paroxetine in plasma by high-performance liquid chromatography for bioequivalence studies.

  1999cited by this paper
• Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma and whole blood by high-performance liquid chromatography with ultraviolet and fluorescence detection.

  1999cited by this paper
• Standards of laboratory practice: antidepressant drug monitoring

  1998cited by this paper
• Rapid simple high-performance liquid chromatographic determination of paroxetine in human plasma.

  1998cited by this paper
• Standards of laboratory practice: antidepressant drug monitoring. National Academy of Clinical Biochemistry.

  1998cited by this paper
• Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry.

  1998cited by this paper
• Metabolism of the Newer Antidepressants

  1998cited by this paper
• Quantitative determination of paroxetine in plasma by high-performance liquid chromatography and ultraviolet detection.

  1997cited by this paper
• Drug points: Acute angle closure glaucoma associated with paroxetine

  1997cited by this paper
• Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors

  1997cited by this paper
• Antidepressant Use in the Elderly

  1997cited by this paper
• Pharmacokinetic-Pharmacodynamic Relationship of the Selective Serotonin Reuptake Inhibitors

  1996cited by this paper
• Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients.

  1996cited by this paper
• The SSRIs: advantages, disadvantages and differences

  1995cited by this paper
• Automated Determination of Paroxetine and Its Main Metabolite by Column Switching and On‐Line High‐Performance Liquid Chromatography

  1994cited by this paper
• Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects

  1994cited by this paper
• Paroxetine. A review of its pharmacology, therapeutic use in depression and therapeutic potential in diabetic neuropathy.

  1993cited by this paper
• Therapeutic drug monitoring. Principles and practice.

  1993cited by this paper
• A Rapid Procedure for the Purification of Biological Samples to be Analyzed by High Performance Liquid Chromatography

  1993cited by this paper
• Treatment of depression in elderly patients with and without dementia disorders.

  1992cited by this paper
• Treatment of Depression in Elderly Patients With and Without Dementia Disorders

  1992cited by this paper
• Determination of paroxetime in human plasma, using high-performance liquid chromatography with fluorescence detection

  1987cited by this paper
• Determination of paroxetine in human plasma, using high-performance liquid chromatography with fluorescence detection.

  1987cited by this paper

• DETERMINATION OF RESIDUAL SOLVENTS IN PAROXETINE BY HEADSPACE GAS CHROMATOGRAPHY

  2019cites this paper
• An improved fabric phase sorptive extraction method for the determination of five selected antidepressant drug residues in human blood serum prior to high performance liquid chromatography with diode array detection.

  2019cites this paper
• Spectrofluorimetric protocol for antidepressant drugs in dosage forms and human plasma through derivatization with dansyl chloride

  2017cites this paper
• Mechanistic considerations of enantiorecognition on novel Cinchona alkaloid-based zwitterionic chiral stationary phases from the aspect of the separation of trans-paroxetine enantiomers as model compounds.

  2016cites this paper
• Micellar High Performance Liquid Chromatographic Method forSimultaneous Determination of Clonazepam and Paroxetine HCl inPharmaceutical Preparations Using Monolithic Column

  2016cites this paper
• An Amperometric Cytochrome P450-2D6 Biosensor System for the Detection of the Selective Serotonin Reuptake Inhibitors (SSRIs) Paroxetine and Fluvoxamine

  2016cites this paper
• Persistent benefits of slow titration of paroxetine in a six‐month follow‐up

  2015cites this paper
• Benefit of slow titration of paroxetine to treat depression in the elderly

  2014cites this paper
• Spectrofluorimetric determination of certain antidepressant drugs in human plasma

  2013cites this paper
• Analytical methods for determination of selective serotonin reuptake inhibitor antidepressants

  2011cites this paper
• Spectrofluorimetric Determination of Paroxetine HCl in Pharmaceuticals via Derivatization with 4-chloro-7- nitrobenzo-2-oxa-1,3-diazole (NBD-Cl)

  2010cites this paper
• Spectrophotometric Determination of the Antidepressants Sertraline and Paroxetine HCl using 2,4-Dinitrofluorobenzene

  2010cites this paper
• Simple Spectrophotometric Method for Determination of Paroxetine in Tablets Using 1,2-Naphthoquinone-4-Sulphonate as a Chromogenic Reagent

  2009cites this paper
• Modern bioanalytical methods for the rapid detection of antidepressants: SNRIs and SSRIs in human biological samples.

  2009cites this paper
• New nonextractive and highly sensitive high-performance liquid chromatographic method for determination of paroxetine in plasma after offline precolumn derivatization with 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole.

  2009cites this paper
• Relevant Issues in the Monitoring and the Toxicology of Antidepressants

  2008cites this paper
• Quantitative analysis of new generation antidepressants using gas chromatography-mass spectrometry: applications in clinical and forensic toxicology

  2008cites this paper
• New Spectrofluorimetric Method with Enhanced Sensitivity for Determination of Paroxetine in Dosage Forms and Plasma

  2008cites this paper
• Relevant issues in the monitoring and the toxicology of antidepressants.

  2008cites this paper
• Determination of the antidepressant paroxetine and its three main metabolites in human plasma by liquid chromatography with fluorescence detection.

  2007cites this paper
• Determination of paroxetine in human plasma by high-performance liquid chromatography using 7,7,8,8-tetracyanoquinodimethane as the derivatization reagent.

  2006cites this paper
• Electroanalytical determination of paroxetine in pharmaceuticals.

  2006cites this paper
• Determination of Paroxetine in Human Plasma by High-Performance Liquid Chromatography Using 7,7,8,8-Tetracyanoquinodimethane as the Derivatization Reagent

  2006cites this paper
• Recent Developments of Achiral HPLC Methods in Pharmaceuticals Using Various Detection Modes

  2004cites this paper
• Current awareness in geriatric psychiatry

  2003cites this paper